MedTech Responds to the Coronavirus
Friday, March 6, 2020
Source: MedTech Association
Friends and Colleagues:
The emergence of Coronavirus Disease 2019 (COVID-19) has profound global impacts that are rapidly evolving. As the voice of New York’s bio/med industry, MedTech is committed to:
- Providing clear, science-based, information;
- Supporting the efforts of member companies developing treatments, vaccines and other COVID-19 modalities;
- Assisting the bio/med industry as it deals with interruptions to the supply chain, travel restrictions, and workforce related issues; and
- Being a responsible actor at events we host and attend.
We are closely monitoring events and over the coming weeks will be communicating with you about COVID-19 and how New York’s bio/med industry is responding. I encourage our members to reach out to us on how we can best help you deal with the disease and its implications for your organization.
Our mission is to develop the relationships, tools and programs that enable New York companies to bring tomorrow’s medical solutions to the healthcare marketplace. That mission has never been more important than it is today.
You may find updates on our webpage here. A link to information from the US Centers for Disease Control is here, and a link to information from the World Health Organization is here.
Below are relevant articles regarding the Coronavirus:
Click here to read "Regeneron CEO hopes to have coronavirus treatment ready for human testing possibly by this summer."